🔎 Trials Near Me

Nyumbani › Unenepu › Arizona › Tucson

Majaribio ya kliniki ya Unenepu katika Tucson, AZ

Masomo 17 ya Unenepu yanatafuta washiriki katika vituo vya Tucson na maeneo yake (ndani ya takriban maili 30). Fungua somo kuona nani anaweza kujiunga na jinsi ya kuwasiliana na timu ya utafiti.

Maandishi rasmi ya utafiti (Kiingereza)

Unavutia washiriki kwa utafiti hapa? Weka juu ya ukurasa huu — $99 kwa siku 30 →

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

InaajiriHatua 2
  • Pima Heart, Tucson
  • Eclipse Clinical Research, Tucson
Umri 18 na zaidi · Jinsia zote · Imesasishwa 30 Sep 2026 · NCT07783802

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

InaajiriHatua 3
  • University of Arizona, Tucson
Umri 6 hadi 17 · Jinsia zote · Imesasishwa 24 Sep 2026 · NCT06672549

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

InaajiriHatua 3
  • Tucson Clinical Research Institute, Tucson
Umri 18 na zaidi · Jinsia zote · Imesasishwa 22 Sep 2026 · NCT07282600

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

InaajiriHatua 3
  • Novak Clinical Research - Tucson - North La Cholla Boulevard, Tucson
Umri 18 na zaidi · Jinsia zote · Imesasishwa 22 Sep 2026 · NCT07392190

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

InaajiriHatua 3
  • Research Site, Tucson
Umri 18 na zaidi · Jinsia zote · Imesasishwa 22 Sep 2026 · NCT07784270

Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight

InaajiriHatua 3
  • Tucson Orthopaedic Institute - North Wyatt Drive, Tucson
Umri 18 na zaidi · Jinsia zote · Imesasishwa 22 Sep 2026 · NCT07353931

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

InaajiriHatua 2
  • The Institute for Liver Health II dba Arizona Liver Health-Tucson, Tucson
Umri 18 hadi 75 · Jinsia zote · Imesasishwa 22 Sep 2026 · NCT07589608

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

InaajiriHatua 3
  • AURORA-1 Clinical Site, Tucson
Umri 18 na zaidi · Jinsia zote · Imesasishwa 16 Sep 2026 · NCT07743463

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

InaajiriHatua 3
  • AURORA-2 Clinical Site, Tucson
Umri 18 na zaidi · Jinsia zote · Imesasishwa 16 Sep 2026 · NCT07743450

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

InaajiriHatua 3
  • Pima Heart and Vascular Clinical Research, Tucson
Umri 18 hadi 99 · Jinsia zote · Imesasishwa 16 Sep 2026 · NCT07037459

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

InaajiriHatua 3
  • Arizona Clinical Trials, Tucson
Umri 18 na zaidi · Jinsia zote · Imesasishwa 14 Sep 2026 · NCT07351058

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes

InaajiriHatua 3
  • Arizona Clinical Trials, Tucson
Umri 18 na zaidi · Jinsia zote · Imesasishwa 14 Sep 2026 · NCT07351045

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

InaajiriHatua 3Wajitolea wenye afya wanakaribishwa
  • ACCOMPLISH-2 Research Site, Tucson
Umri 18 hadi 79 · Jinsia zote · Imesasishwa 11 Sep 2026 · NCT07654374

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

InaajiriHatua 2
  • The Institute for Liver Health II dba Arizona Liver Health-Tucson, Tucson
Umri 18 hadi 75 · Jinsia zote · Imesasishwa 8 Sep 2026 · NCT06143956

A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes

InaajiriHatua 2
  • Pima Heart, Tucson
Umri 18 hadi 75 · Jinsia zote · Imesasishwa 8 Sep 2026 · NCT07215559

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

InaajiriHatua 3
  • ACCOMPLISH-1 Research Site, Tucson
Umri 18 hadi 79 · Jinsia zote · Imesasishwa 10 Ago 2026 · NCT07654361

Majaribio ya Unenepu katika miji mingine

Masomo mengine katika Tucson

Kutoka ClinicalTrials.gov, data iliyopatikana 5 Okt 2026. Kila utafiti una masharti yake ya kufaa; timu ya utafiti huamua nani anaweza kujiunga.